Loss of E-cadherin is a major driver event in breast cancer, with its coding gene CDH1 mutated in ∼11% of all breast tumors and over 50% of invasive lobular breast tumors (Berx et al., 1995, Ciriello et al., 2015, Michaut et al., 2016). This evidence concerns the gene CDH1 and breast cancer.